Kappa Free Light Chains in MS and CIS
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at a protein called kappa free light chains (KFLC) in the spinal fluid and blood of people with multiple sclerosis (MS) or a first MS-like episode (CIS). The goal is to better understand how this protein relates to the disease, which may help with diagnosis and monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with multiple sclerosis (MS) or a first episode of MS-like symptoms (called clinically isolated syndrome or CIS).
- You must be between 18 and 70 years old.
- You must have had a lumbar puncture (spinal tap) and a blood draw, and the samples must be available for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks specific proteins in spinal fluid to see whether they can predict how multiple sclerosis (or related symptoms like optic neuritis) may go over time. It may help doctors better estimate prognosis using results from tests you may already be having.
This study looks at different immune cells in blood and, sometimes, spinal fluid (CSF) to understand what’s driving multiple sclerosis (MS) or early MS-like symptoms. Your participation may help researchers better explain the disease and potentially improve how it’s diagnosed or treated.
This study looks at a protein called FCRL5 in your blood to see if it is linked to multiple sclerosis and how well treatments work. It also includes people with Sjögren's syndrome and healthy volunteers for comparison. You may be asked to give blood samples and answer some questions.
This study follows people with multiple sclerosis (MS) or a related condition to learn how pregnancy affects MS. You may be asked to complete health questionnaires and get MRI scans, which can help researchers understand what changes during pregnancy.
This is a registry study that collects health information from people with multiple sclerosis and related conditions. By joining, you help researchers better understand these diseases and improve future treatments.
This study looks at genetic information and blood test signals to understand why some people with early MS develop a worse outcome. It may help doctors predict who is at higher risk and better understand disease mechanisms.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.